# Frank Stegmeier

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/frank-stegmeier/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,757 |
| Field | CRISPR and Genetic Engineering |
| h-index | 36 |
| i10-index | 41 |
| Last Known Institution | Q Therapeutics (United States) |
| OpenAlex ID | https://openalex.org/A5026781698 |
| Works | 132 |

## Researcher papers

- [Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition](https://scholariq.org/papers/tumor-cells-can-follow-distinct-evolutionary-paths-to-become-resistant-to/)

## Researcher topics

- [CRISPR and Genetic Engineering](https://scholariq.org/topics/crispr-and-genetic-engineering/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Microtubule and mitosis dynamics](https://scholariq.org/topics/microtubule-and-mitosis-dynamics/)

## Researcher university

- [Q Therapeutics (United States)](https://scholariq.org/institutions/q-therapeutics-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.